4//SEC Filing
TAYTON-MARTIN HELEN KATRINA 4
Accession 0001104659-20-004422
CIK 0001621227other
Filed
Jan 14, 7:00 PM ET
Accepted
Jan 15, 8:02 PM ET
Size
7.2 KB
Accession
0001104659-20-004422
Insider Transaction Report
Form 4
TAYTON-MARTIN HELEN KATRINA
Chief Operating Officer
Transactions
- Sale
American Depositary Shares
2020-01-13$4.00/sh−50,000$200,000→ 0 total - Sale
American Depositary Shares
2020-01-13$5.00/sh−50,000$250,000→ 0 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 28, 2019.
- [F2]These ADSs were sold in multiple transactions at a price of $4.00. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission full information regarding the ADSs sold at this price in this footnote.
- [F3]These ADSs were sold in multiple transactions at a price of $5.00. Upon request, the reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission full information regarding the ADSs sold at this price in this footnote.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001661780
Filing Metadata
- Form type
- 4
- Filed
- Jan 14, 7:00 PM ET
- Accepted
- Jan 15, 8:02 PM ET
- Size
- 7.2 KB